Nanothecin

N/A

Report date: 2023/01/16 10:11:24
NME

Base Information

Drug NameNanothecin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsColorectal NeoplasmsPeritoneal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrititech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrititech Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsColorectal NeoplasmsPeritoneal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A